Compounds > efavirenz

efavirenz and AIDS-Related Opportunistic Infections

efavirenz has been researched along with AIDS-Related Opportunistic Infections in 43 studies

Research

Studies (43)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (9.30)18.2507
2000's19 (44.19)29.6817
2010's17 (39.53)24.3611
2020's3 (6.98)2.80

Authors

AuthorsStudies
Dandara, C; Maponga, C; Mhandire, D; Mhandire, K; Morse, G1
George, PE; Mercedes, R; Nabukeera-Barungi, N; Otto, SBJ1
Arellano, J; Corredoira, Y; Gonzalez, R; Nuñez, R1
Abgrall, S; Arribas, JR; Barger, D; Barrufet, P; Braun, D; Caniglia, EC; Cardoso, SW; Chrysos, G; Costagliola, D; Gill, J; Gogos, C; Hauser, C; Hernán, MA; Hoyos, SP; Justice, A; Leyes, M; Lodi, S; Logan, R; Meyer, L; Moreno, S; Muga, R; Pacheco, A; Phillips, A; Porter, K; Reiss, P; Sabin, CA; Seng, R; Tate, J; van Sighem, A; Vandenhende, MA; Winston, A1
Beck, IA; Birch, D; Bolton-Moore, C; Bwakura-Dangarembizi, M; Capparelli, E; Chadwick, E; Frenkel, LM; Higa, N; Pelz, A; Samson, P; Sils, T1
Bastos, R; Baudin, E; Bhatt, N; Bonnet, M; Calmy, A; Ciaffi, L; Jani, I; Michon, C; Nunes, E; Rouzioux, C; Silva, C; Sobry, A; Taburet, AM1
Bookstaver, PB; Caulder, CR; Kelly, LS1
Bekker, LG; Gupta-Wright, A; Lawn, SD; Wood, R1
Cardoso, SV; de Faria, PR; Loyola, AM; Servato, JP; Spini, PH; Spini, TH1
Mitra, AK; Pal, D; Patel, M; Paturi, DK; Vadlapatla, RK1
Arnold, V; Barcellos, NT; Brites, C; Chêne, G; De Castro, N; Delaugerre, C; Fagard, C; Grinsztejn, B; Madruga, JV; Molina, JM; Morgado, M; Patey, O; Pilotto, JH; Santini-Oliveira, M; Santos, BR; Veloso, VG; Vorsatz, C1
Alanio, A; De Castro, N; Gaube, G; Gueguen, A; Lascoux, C; Molina, JM; Zagdanski, AM1
Alfaro, RM; Calderón, MM; Kovacs, JA; Kumar, P; McManus, M; Pau, AK; Penzak, SR1
Branco, T; Caixas, U; Germano, I; Lampreia, F; Monteiro, EC; Papoila, AL; Pereira, SA1
Djoerban, Z; Sumantri, S1
Brouwer, AM; Burger, DM; de Lange, W; van der Ven, A; van Luin, M; van Schaik, RH1
Carbonara, S; Ciracì, E; Cusato, M; Heichen, M; Monno, L; Regazzi, M; Stano, F; Villani, P1
Lavae-Mokhtari, M; Mohammad-Khani, S; Schmidt, RE; Stoll, M1
Battegay, M; Bernasconi, E; Cavassini, M; Elzi, L; Furrer, H; Hirschel, B; Ledergerber, B; Marzolini, C; Vernazza, P; Weber, R1
Asselman, V; Boulle, A; Marais, S; Meintjes, G; Pepper, DJ; Thienemann, F; Wilkinson, RJ1
Cohen, K; Conradie, F; Ive, P; Orrell, C; Sanne, I; Wood, R; Zeinecker, J1
Chang, CM; Chen, HT; Chu, WL; Hsieh, LY; Ko, NY; Ko, WC; Lauderale, TL; Lee, HC; Lee, NY; Lin, CC; Lo, HJ; Tseng, FC; Wang, YL; Wu, CJ; Yang, YL1
Aklillu, E; Bakari, M; Janabi, MY; Lindquist, L; Minzi, OM; Mugusi, FM; Mugusi, SF; Ngaimisi, E; Sandstrom, EG; Sasi, PG1
Lu, HZ; Shen, YZ; Wang, ZY1
Bellamy, S; Bisson, GP; Gluckman, S; Molefi, M; Rantleru, T; Ravimohan, S; Steenhoff, A; Tamuhla, N; Tebas, P; Thakur, R; Tsimako, I; Weissman, D1
Alarcón-González, A; Gómez-Mateos, J; León-Jimenez, E; López-Cortés, LF; López-Pua, Y; Pachón, J; Ruiz-Valderas, R; Sarasanacenta, M; Viciana, P1
Arribas, JR; Costa, MA; Del Palacio, A; Gatell, JM; González, J; Lonca, M; Lorenzo, A; Miró, JM; Peña, JM; Pulido, F; Rubio, R; Torralba, M; Vázquez, JJ1
Adonis-Koffy, L; Fassinou, P; N'dja, BB; Timité-Konan, AM1
Kiertiburanakul, S; Mahanontharit, A; Manosuthi, W; Prasithsirikul, W; Rattanasiri, S; Ruxrungtham, K; Sankote, J; Sungkanuparph, S; Thakkinstian, A; Vibhagool, A1
Brennan-Benson, P; Harrison, T; Lyus, R; Macallan, D; Pakianathan, M1
Boyd, MA; Burger, DM; Cooper, DA; Phanuphak, P1
Diller, R; Thompson, K1
Jaruratanasirikul, S; Mahatthanatrakul, W; Ridtitid, W; Sriwiriyajan, S1
Chimsuntorn, S; Lueangniyomkul, A; Mankatitham, W; Manosuthi, W; Sungkanuparph, S1
Boyle, BA; Goldenberg, D1
Bartnof, HS1
Bartlett, JG1
Bartnoff, H; Deeks, S; Follansbee, S1
Agosto, M1
de Alarcón, A; López-Cortés, LF; Viciana, P1
Campelli, A; Indiveri, F; Murdaca, G; Puppo, F; Setti, M1
Fernando, R; Miller, R1
Diaz, B; Martín-Carbonero, L; Pérez-Olmeda, M; Soriano, V1

Reviews

1 review(s) available for efavirenz and AIDS-Related Opportunistic Infections

ArticleYear
Clinically relevant drug-drug interactions between antiretrovirals and antifungals.
    Expert opinion on drug metabolism & toxicology, 2014, Volume: 10, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Carbamates; Cyclopropanes; Drug Interactions; Drug Monitoring; Echinocandins; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Itraconazole; Mycoses; Organophosphates; Pyrimidines; Ritonavir; Sulfonamides; Triazoles; Voriconazole

2014

Trials

9 trial(s) available for efavirenz and AIDS-Related Opportunistic Infections

ArticleYear
Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.
    The Lancet. Infectious diseases, 2013, Volume: 13, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Coinfection; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Mozambique; Nevirapine; Treatment Outcome; Tuberculosis; Tuberculosis, Pulmonary

2013
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial.
    The Lancet. Infectious diseases, 2014, Volume: 14, Issue:6

    Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Brazil; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; France; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Pyrrolidinones; Raltegravir Potassium; RNA, Viral; Tenofovir; Treatment Outcome; Tuberculosis; Viral Load

2014
Efavirenz but Not Atazanavir/Ritonavir Significantly Reduces Atovaquone Concentrations in HIV-Infected Subjects.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016, Apr-15, Volume: 62, Issue:8

    Topics: Administration, Oral; Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Anti-Infective Agents; Atazanavir Sulfate; Atovaquone; Benzoxazines; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Encephalitis; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Pneumonia, Pneumocystis; Reverse Transcriptase Inhibitors; Ritonavir; Toxoplasmosis, Cerebral; Young Adult

2016
Efavirenz and rifampicin in the South African context: is there a need to dose-increase efavirenz with concurrent rifampicin therapy?
    Antiviral therapy, 2011, Volume: 16, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Reverse Transcriptase Inhibitors; Rifampin; South Africa; Treatment Outcome; Tuberculosis

2011
Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013, Volume: 56, Issue:8

    Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Alkynes; Amphotericin B; Anti-HIV Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Colony Count, Microbial; Cyclopropanes; Deoxycytidine; Emtricitabine; Female; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Meningitis, Cryptococcal; Organophosphonates; Survival Analysis; Tenofovir; Treatment Outcome

2013
Pharmacokinetic interactions between efavirenz and rifampicin in HIV-infected patients with tuberculosis.
    Clinical pharmacokinetics, 2002, Volume: 41, Issue:9

    Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Interactions; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Oxazines; Rifampin; Tuberculosis

2002
High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/microl and opportunistic diseases: the EfaVIP Study (Efavirenz in Very Immunosuppressed Patients).
    AIDS (London, England), 2002, Jul-26, Volume: 16, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV-1; Humans; Immunocompromised Host; Male; Middle Aged; Oxazines; Recurrence; Retrospective Studies

2002
Efavirenz levels and 24-week efficacy in HIV-infected patients with tuberculosis receiving highly active antiretroviral therapy and rifampicin.
    AIDS (London, England), 2005, Sep-23, Volume: 19, Issue:14

    Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antibiotics, Antitubercular; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Dose-Response Relationship, Drug; Female; HIV-1; Humans; Male; Middle Aged; Oxazines; Rifampin; RNA, Viral; Treatment Outcome; Tuberculosis

2005
Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients.
    European journal of clinical pharmacology, 2007, Volume: 63, Issue:5

    Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Area Under Curve; Benzoxazines; Candidiasis, Oral; Cyclopropanes; Drug Interactions; Female; Half-Life; HIV Infections; Humans; Ketoconazole; Lamivudine; Male; Middle Aged; Stavudine

2007

Other Studies

33 other study(ies) available for efavirenz and AIDS-Related Opportunistic Infections

ArticleYear
Plasma efavirenz concentration inversely correlates with increased risk of cytomegalovirus infection in HIV-infected pregnant women.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2019, Dec-12, Volume: 110, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Benzoxazines; Coinfection; Cross-Sectional Studies; Cyclopropanes; Cytomegalovirus Infections; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Reverse Transcriptase Inhibitors; Risk Factors

2019
Cryptococcal meningitis and immune reconstitution inflammatory syndrome in a pediatric patient with HIV after switching to second line antiretroviral therapy: a case report.
    BMC infectious diseases, 2020, Jan-21, Volume: 20, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Antigens, Fungal; Benzoxazines; Child; Cryptococcus neoformans; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Female; Fluconazole; HIV; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Lopinavir; Meningitis, Cryptococcal; Ritonavir; Treatment Outcome; Viral Load; Zidovudine

2020
Diagnosis of elephantiasis nostras verrucosa as a clinical mani-festation of Kaposi's sarcoma.
    Medwave, 2020, Jan-20, Volume: 20, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Didanosine; Drug Therapy, Combination; Elephantiasis; Humans; Lamivudine; Male; Middle Aged; Sarcoma, Kaposi

2020
Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions.
    Journal of acquired immune deficiency syndromes (1999), 2018, 01-01, Volume: 77, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Alkynes; Americas; Atazanavir Sulfate; Benzoxazines; Cohort Studies; Cyclopropanes; Darunavir; Europe; Female; HIV Protease Inhibitors; Humans; Leukoencephalopathy, Progressive Multifocal; Lopinavir; Male; Meningitis, Cryptococcal; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Toxoplasmosis

2018
Association of Virologic Failure and Nonnucleoside Reverse Transcriptase Inhibitor Resistance Found in Antiretroviral-Naive Children Infected With Human Immunodeficiency Virus and Given Efavirenz-Based Treatment.
    Journal of the Pediatric Infectious Diseases Society, 2020, Apr-30, Volume: 9, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Benzoxazines; Child, Preschool; Cyclopropanes; Drug Resistance, Viral; Female; Genotype; HIV Infections; HIV-1; Humans; Infant; Male; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Failure; Tuberculosis

2020
Timely formulary management for preventing errors related to antiretroviral drugs.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, Jun-15, Volume: 70, Issue:12

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Drug Resistance, Viral; Humans; Infectious Disease Medicine; Interdisciplinary Communication; Male; Medical Order Entry Systems; Medication Errors; Middle Aged; Nitriles; Pharmacy Service, Hospital; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Workforce

2013
Temporal association between incident tuberculosis and poor virological outcomes in a South African antiretroviral treatment service.
    Journal of acquired immune deficiency syndromes (1999), 2013, Nov-01, Volume: 64, Issue:3

    Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Lamivudine; Male; Medication Adherence; Nevirapine; Risk Factors; South Africa; Stavudine; Time Factors; Tuberculosis; Viral Load

2013
Regression of oral Kaposi's sarcoma after combination antiretroviral therapy.
    Infection, 2013, Volume: 41, Issue:6

    Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; Humans; Lamivudine; Male; Organophosphonates; Sarcoma, Kaposi; Tenofovir

2013
Treatment with adalimumab for severe immune reconstitution inflammatory syndrome in an HIV-infected patient presenting with cryptococcal meningitis.
    Medecine et maladies infectieuses, 2016, Volume: 46, Issue:3

    Topics: Adalimumab; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Anti-Inflammatory Agents; Antifungal Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cameroon; Combined Modality Therapy; Cyclopropanes; Delayed Diagnosis; Drug Therapy, Combination; Female; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Meningitis, Cryptococcal; Prednisone; Stavudine; Tumor Necrosis Factor-alpha; Ventriculoperitoneal Shunt

2016
Efavirenz concentrations in HIV-infected patients with and without viral hepatitis.
    British journal of clinical pharmacology, 2008, Volume: 66, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Benzoxazines; Case-Control Studies; CD4 Lymphocyte Count; Cyclopropanes; Disease Progression; Dose-Response Relationship, Drug; Drug Monitoring; Female; Follow-Up Studies; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Liver Diseases; Male; Pilot Projects; Reverse Transcriptase Inhibitors; Severity of Illness Index; Treatment Outcome; Viral Load

2008
Clinical manifestations and antiretroviral management of HIV/AIDS patients with tuberculosis co-infection in Kramat 128 Hospital.
    Acta medica Indonesiana, 2008, Volume: 40, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Anti-Retroviral Agents; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Female; HIV Infections; Humans; Indonesia; Male; Middle Aged; Nevirapine; Outpatient Clinics, Hospital; Outpatients; Risk Factors; Treatment Outcome; Tuberculosis, Pulmonary

2008
Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin.
    AIDS (London, England), 2009, Mar-27, Volume: 23, Issue:6

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antibiotics, Antitubercular; Benzoxazines; Cyclopropanes; Drug Interactions; Humans; Male; Middle Aged; Rifampin; Tuberculosis

2009
Long-term efficacy and safety of TDM-assisted combination of voriconazole plus efavirenz in an AIDS patient with cryptococcosis and liver cirrhosis.
    The Annals of pharmacotherapy, 2009, Volume: 43, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazines; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; Humans; Liver Cirrhosis; Male; Meningitis, Cryptococcal; Pyrimidines; Triazoles; Voriconazole

2009
[Acute renal failure and hypercalcemia in an AIDS patient on tenofovir and low-dose vitamin D therapy with immune reconstitution inflammatory syndrome].
    Medizinische Klinik (Munich, Germany : 1983), 2009, Oct-15, Volume: 104, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Acute Kidney Injury; Adenine; Adrenal Cortex Hormones; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Calcium; Cholecalciferol; Cyclopropanes; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Emtricitabine; Female; Humans; Hypercalcemia; Immune Reconstitution Inflammatory Syndrome; Kidney Function Tests; Mycobacterium avium-intracellulare Infection; Organophosphonates; Osteoporosis; Tenofovir

2009
Treatment modification in human immunodeficiency virus-infected individuals starting combination antiretroviral therapy between 2005 and 2008.
    Archives of internal medicine, 2010, Jan-11, Volume: 170, Issue:1

    Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Therapy, Combination; Emtricitabine; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Nevirapine; Oligopeptides; Organophosphonates; Proportional Hazards Models; Prospective Studies; Pyridines; Pyrimidinones; Risk Factors; Switzerland; Tenofovir; Zidovudine

2010
Central nervous system disorders after starting antiretroviral therapy in South Africa.
    AIDS (London, England), 2010, Nov-27, Volume: 24, Issue:18

    Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV Seropositivity; Humans; Immune Reconstitution Inflammatory Syndrome; Male; Middle Aged; Prospective Studies; South Africa; Young Adult

2010
Oropharyngeal yeast colonization in HIV-infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:5

    Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Benzoxazines; Candida; Candidiasis, Oral; CD4 Lymphocyte Count; Cross-Sectional Studies; Cyclopropanes; Female; Fluconazole; HIV Infections; HIV-1; Humans; Male; Middle Aged; Oropharynx; Outpatients; Prospective Studies; Reverse Transcriptase Inhibitors; Substance Abuse, Intravenous; Taiwan; Young Adult

2012
Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania.
    Antiviral therapy, 2012, Volume: 17, Issue:2

    Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Candidiasis, Oral; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cohort Studies; Coinfection; Cyclopropanes; Female; HIV Infections; Humans; Karnofsky Performance Status; Leukocyte Count; Male; Middle Aged; Risk Factors; Sarcoma, Kaposi; Tanzania; Tuberculosis

2012
Penicillium marneffei chylous ascites in acquired immune deficiency syndrome: a case report.
    World journal of gastroenterology, 2012, Oct-07, Volume: 18, Issue:37

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Alkynes; Amphotericin B; Anti-Retroviral Agents; Antifungal Agents; Benzoxazines; Chylous Ascites; Cyclopropanes; Diagnosis, Differential; Humans; Male; Middle Aged; Mycoses; Penicillium; Pyrimidines; Sepsis; Triazoles; Voriconazole

2012
[Use of antiretroviral drugs in HIV infected children in a tropical area: a real benefit].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2003, Volume: 10, Issue:9

    Topics: Adolescent; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Child; Child, Preschool; Cohort Studies; Comorbidity; Cote d'Ivoire; Cyclopropanes; Developing Countries; Female; HIV Infections; HIV Protease Inhibitors; Humans; Infant; Male; Malnutrition; Nelfinavir; Oxazines; Reverse Transcriptase Inhibitors; Treatment Outcome

2003
Pharmacokinetic interactions between efavirenz and rifampicin in the treatment of HIV and tuberculosis: one size does not fit all.
    AIDS (London, England), 2005, Sep-23, Volume: 19, Issue:14

    Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antibiotics, Antitubercular; Benzoxazines; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Oxazines; Rifampin; Tuberculosis

2005
Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis.
    AIDS (London, England), 2006, Apr-24, Volume: 20, Issue:7

    Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Cyclopropanes; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Male; Oxazines; Ritonavir; Treatment Outcome; Tuberculosis, Pulmonary

2006
Visual loss secondary to acquired immunodeficiency virus-related progressive multifocal leukoencephalopathy demonstrating clinical improvement with highly active antiretroviral therapy.
    Optometry (St. Louis, Mo.), 2007, Volume: 78, Issue:2

    Topics: Adenine; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cerebrospinal Fluid; Cyclopropanes; Drug Therapy, Combination; Hemianopsia; Humans; JC Virus; Lamivudine; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Middle Aged; Organophosphonates; Oxazines; Tenofovir; Tomography, X-Ray Computed; Vision Disorders; Visual Fields

2007
Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin.
    HIV medicine, 2008, Volume: 9, Issue:5

    Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Antitubercular Agents; Benzoxazines; CD4 Lymphocyte Count; Cohort Studies; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Male; Nevirapine; Retrospective Studies; Reverse Transcriptase Inhibitors; Rifampin; Treatment Outcome; Tuberculosis; Viral Load

2008
Current issues in antiretroviral and psychiatric therapy for HIV-infected patients.
    The AIDS reader, 2000, Volume: 10, Issue:9

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Infections; Humans; Mental Disorders; Oxazines; Pneumonia, Pneumocystis; Viremia

2000
Selected highlights from the 5th Conference on Retroviruses and Opportunistic Infections.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1998

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antiviral Agents; Benzoxazines; Carbamates; Chicago; Clinical Trials as Topic; Congresses as Topic; Cyclopropanes; Dideoxynucleosides; Drug Hypersensitivity; Drug Interactions; Drug Therapy, Combination; Drugs, Investigational; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Oxazines; Reverse Transcriptase Inhibitors; Sulfonamides

1998
Report on HIV/AIDS from IDSA: news from the mile high city.
    The Hopkins HIV report : a bimonthly newsletter for healthcare providers, 1999, Volume: 11, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Benzoxazines; Colorado; Cyclopropanes; Dideoxynucleosides; Drug Interactions; Drug Therapy, Combination; HIV Infections; Humans; Interleukin-2; Oxazines; Pneumonia, Pneumocystis; Practice Patterns, Physicians'; Reverse Transcriptase Inhibitors; Tuberculosis; United States

1999
Fifth Conference on Retroviruses & Opportunistic Infections. Interview by Ron Baker.
    Newsline (People with AIDS Coalition of New York), 1998

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; Clinical Trials as Topic; Congresses as Topic; Cyclopropanes; Dideoxynucleosides; Drug Resistance, Microbial; Drug Therapy, Combination; Drugs, Investigational; Furans; Genetic Techniques; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxyurea; Oxazines; Reverse Transcriptase Inhibitors; Sulfonamides; Viral Load

1998
Moving forward: a treatment overview from the 12th World AIDS Conference.
    Newsline (People with AIDS Coalition of New York), 1998

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Benzoxazines; Carbamates; CD4-Positive T-Lymphocytes; Clinical Trials as Topic; Congresses as Topic; Cyclopropanes; Dideoxynucleosides; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Furans; Health Services Accessibility; HIV Protease Inhibitors; Humans; Hydroxyurea; Lopinavir; Oxazines; Patient Care Planning; Pyrimidinones; Remission Induction; Reverse Transcriptase Inhibitors; Sulfonamides; Switzerland; Virus Replication

1998
Efavirenz plasma concentrations and efficiency.
    AIDS (London, England), 2001, Jun-15, Volume: 15, Issue:9

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dose-Response Relationship, Drug; Humans; Oxazines; Reverse Transcriptase Inhibitors; Treatment Outcome; Tuberculosis; Viral Load

2001
Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor.
    AIDS (London, England), 2002, Jan-25, Volume: 16, Issue:2

    Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; HIV-1; Homosexuality, Male; Humans; Lamivudine; Male; Nucleosides; Oxazines; Reverse Transcriptase Inhibitors; RNA, Viral; Sarcoma, Kaposi; Treatment Outcome; Viral Load; Zidovudine

2002
Immune reconstitution eosinophilia due to schistosomiasis.
    Sexually transmitted infections, 2002, Volume: 78, Issue:1

    Topics: Adult; AIDS-Related Opportunistic Infections; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Eosinophilia; Female; Humans; Lamivudine; Oxazines; Schistosomiasis; Stavudine

2002
Normalization of liver enzymes in an HIV-hepatitis C virus-co-infected patient after potent antiretroviral therapy.
    AIDS (London, England), 2002, May-24, Volume: 16, Issue:8

    Topics: Adult; AIDS-Related Opportunistic Infections; Alanine Transaminase; Alkynes; Anti-HIV Agents; Aspartate Aminotransferases; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Drug Therapy, Combination; Female; Hepatitis C; Humans; Lamivudine; Liver; Oxazines; RNA, Viral; Zidovudine

2002